Regeneron Pharmaceuticals, Inc. (REGN) — DEF 14A Filings
All DEF 14A filings from Regeneron Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Regeneron Files 2025 Proxy Statement on Executive Compensation
— Apr 29, 2025 Risk: low
Regeneron Pharmaceuticals, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 29, 2025, for the fiscal year ending December 31, 2024. The filing detai -
Regeneron Pharmaceuticals Files Definitive Proxy Statement
— Apr 25, 2024 Risk:
REGENERON PHARMACEUTICALS, INC. (REGN) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Regeneron Pharmaceuticals, Inc. filed its Definitive Pr
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX